|
US2021107940A1
|
|
14-3-3 targeting peptides for cancer treatment
|
|
US2020331897A1
|
|
Chemical Probes to Identify Anti-Mycobacterial MmpL3 Inhibitors
|
|
US2018243419A1
|
|
Liposomal compositions with light illumination-induced drug release
|
|
US2018193365A1
|
|
Use of hydrogen sulfide to prevent lens opacification
|
|
US2018036283A1
|
|
Indole-based therapeutics
|
|
US2017290819A1
|
|
Small molecule therapies for pulmonary hypertension
|
|
US2018259438A1
|
|
Diffusion cells and related methods
|
|
US10907217B1
|
|
High resolution melt-curve analysis to identify the sequence type of E. coli
|
|
US9925185B1
|
|
Treatment and prevention methods for mammalian neurosensory hair cells loss
|
|
US2015164857A1
|
|
Seizure therapy
|
|
AU2012202805A1
|
|
Estrogen receptors and methods of use
|
|
AU2012250610A2
|
|
Use of radiographic contrast agents for detecting dental caries
|
|
AU2007200352A1
|
|
The high bone mass gene of 11q13.3
|
|
AU2006202206A1
|
|
Compositions derived from modiolus modiolus and methods for making and using the same
|
|
AU2005284803A1
|
|
Device and method for detecting antibiotic-inactivating enzymes
|
|
AU2004271214A2
|
|
Primers for use in detecting beta-lactamases
|
|
AU2004243016A1
|
|
Methods and materials for treating, detecting, and reducing the risk of developing Alzheimer's Disease
|
|
AU2003254012A1
|
|
Device and method for detecting antibiotic inactivating enzymes
|
|
AU2002231190B2
|
|
Methods for inducing apoptosis and inhibiting proliferation in cancer cells
|
